The glucagon response to insulin-induced hypoglycemia (IIH) is markedly impaired early in type 1 diabetes, We have previously demonstrated that this glucagon response is largely autonomically mediated in nondiabetic animals and humans. More recently we discovered an early sympathetic islet neuropathy (eSIN) in human subjects with type 1 diabetes and animal models thereof and therefore hypothesized that eSIN contributes to this glucagon impairment. Therefore, the purpose of this grant is to determine the mechanism by which 1) only sympathetic nerves are lost, 2) only from the islets and 3) only in autoimmune diabetes. The mechanism that accounts for all three is based on emerging concepts in developmental neurobiology. We propose that brain derived neurotrophic factor (BDNF), secreted by B-lymphocytes invading the islet during the development of autoimmune diabetes, shifts the balance of islet neurotrophins away from axonal maintenance via Trk receptors towards axonal pruning via the p75 pan-neurotrophin receptor (NTR), causing a selective loss of islet sympathetic nerves and thereby dysfunction of the sympathetic alpha-cell pathway. Therefore our first Specific Aim is to demonstrate the necessity of BDNF for the immune-mediated loss of islet sympathetic nerves and for the retention of islet parasympathetic nerves. We will demonstrate the presence of BDNF in the diabetic islet by immunohistochemistry and RTC-PCR. We will demonstrate its sympathetic neurotoxicity by knocking out BDNF. We will rescue islet sympathetic nerves by transducing them to ectopically express the axonal maintenance receptor that is both present on parasympathetic nerves and activated by BDNF. In our second Specific Aim we will demonstrate the necessity of B-lymphocytes by knocking them out, thus preventing the loss of islet sympathetic nerves despite the presence of immune-mediated diabetes. In our third Specific Aim we will prevent the loss of islet sympathetic nerves either by knocking out p75NTR or by transducing sympathetic neurons to express NGF that activates TrkA, their endogenous axonal maintenance receptor. Significance: Determining the mechanism of the loss of islet sympathetic nerves in type 1 diabetes will allow us to prevent or reverse that loss. Since we have previously shown that the sympathetic alpha cell pathway is activated during IIH and contributes to the glucagon response to IIH, we expect such prevention to improve this glucagon response in type 1 diabetes. Such improvement will allow more intensive treatment of patients with type 1 diabetes which will in turn help prevent the long-term complications of this disease.

Public Health Relevance

This grant seeks to understand why certain nerves are lost from the islets of people with type 1 diabetes. That understanding will allow us to prevent the nerve loss, which in turn should reduce the incidence of hypoglycemia during diabetes treatment. Prevention of hypoglycemia will allow tighter control of blood sugar, which is known to reduce the long-term complications of diabetes.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Arreaza-Rubin, Guillermo
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Seattle Institute for Biomedical/Clinical Research
United States
Zip Code
Morton, Gregory J; Muta, Kenjiro; Kaiyala, Karl J et al. (2017) Evidence That the Sympathetic Nervous System Elicits Rapid, Coordinated, and Reciprocal Adjustments of Insulin Secretion and Insulin Sensitivity During Cold Exposure. Diabetes 66:823-834
Meek, Thomas H; Dorfman, Mauricio D; Matsen, Miles E et al. (2015) Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia. Diabetes 64:2376-87
Meek, Thomas H; Wisse, Brent E; Thaler, Joshua P et al. (2013) BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production. Diabetes 62:1512-8
Meek, Thomas H; Matsen, Miles E; Dorfman, Mauricio D et al. (2013) Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia. Endocrinology 154:3067-76
German, Jonathan P; Thaler, Joshua P; Wisse, Brent E et al. (2011) Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152:394-404
German, Jonathan P; Wisse, Brent E; Thaler, Joshua P et al. (2010) Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes 59:1626-34